Third Apotex plant cited in FDA warning letter
April 19, 2010Manufacturing and Production Apotex, generics, manufacturing compliance
Canada’s Apotex has been sent a warning letter citing manufacturing violations at a facility in Toronto that are identical to …
Trial boost for Merck KGaA’s cladribine
April 19, 2010Research and Development Cladribine, MS, Merck KGaA, Merck Serono
New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …
Novartis set to boost generic portfolio
April 19, 2010Sales and Marketing Novartis, Sandoz, generics
Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …
MedImmune: building a biologics future
April 19, 2010Research and Development MedImmune, biologics
I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Action Pharma appoints new chief executive
April 19, 2010Research and Development Action Pharma, appointment, research and development
Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Lane Earl Cox wins allergy blood test account
April 16, 2010Medical Communications LEC, Phadia, allergy
Healthcare advertising agency Lane Earl & Cox has won the account to promote an allergy blood test product from diagnostics …
Genzyme appoint investor to outmanoeuvre Icahn
April 16, 2010Sales and Marketing Contamination, Genzyme
Genzyme has appointed the head of one of its biggest shareholders to its board in order to block a hostile …
Pharma manufacturing news in brief
April 16, 2010Manufacturing and Production
A round-up of news in the pharmaceutical manufacturing arena includes the removal of CFC-based MDIs from the US market, facility …
Emerging markets lift Roche in Q1
April 16, 2010Sales and Marketing Roche, emerging markets
Roche saw its sales grow 9% overall in the first quarter, with emerging markets medicines revenues showing a healthy 38% …
Maike Fieber joins Photosound
April 16, 2010Medical Communications Photosound, appointment, medical communications
Photosound has appointed Maike Fieber as an account manager.She joins the agency from Ogilvy & Mather in Dusseldorf, where she …
Cephalon completes acquisition of generics firm Mepha
April 16, 2010Sales and Marketing Cephalon, generics
Specialist pharmaceutical company Cephalon has completed the $615.4 million acquisition of Mepha. Based in Switzerland, Mepha specialises in using reformulation …
Digital Pharma: Online ‘keepy uppies’ from Bayer
April 15, 2010Medical Communications Bayer Schering Pharma, Langland, digi game, digital pharma, disease awareness campaigns, haemophilia, iphone
Bayer Schering Pharma is counting down to World Haemophilia Day with a football-themed online disease awareness campaign. The centre-piece of …
Lixisenatide scores in phase III trial
April 15, 2010Research and Development GLP-1, Lixisenatide, diabetes
Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …
Healthcare key to voting preferences
April 15, 2010NHS, election
Healthcare is a key factor when deciding which political candidate to support for more than half of UK voters, according …
Hikma expands in Middle East & North Africa
April 15, 2010Manufacturing and Production, Sales and Marketing Hikma, em
UK-headquartered Hikma Pharmaceuticals has signed a flurry of deals that expand its position in the fast-growing Middle East and North …
Fred Hassan moves to Bausch & Lomb
April 15, 2010Sales and Marketing Bausch and Lomb, appointment, sales and marketing
Pharma industry veteran Fred Hassan has been appointed chairman at eye health company Bausch & Lomb. Hassan was previously chairman …
Abbott chief exec ordered to hand over email records
April 14, 2010Sales and Marketing Abbott, conduct
A US judge has ordered Abbott to give prosecutors access to company emails, including those sent by chief executive Miles …
Patients ignorant of blood clot risks
April 14, 2010Sales and Marketing Pradaxa, VTE, thrombosis
Many patients are not aware that they are at risk from blood clots when staying in hospital, according to new …
Gilenia cuts relapse rates in MS patients
April 14, 2010Sales and Marketing Gilena, MS, Novartis
Novartis’ new oral multiple sclerosis treatment Gilenia has been shown to reduce relapse rates significantly in new trial data.Data presented …
Just how resilient are you?
April 14, 2010Business Services careers, work life balance
The concept of ‘resilience’ in relation to our working lives has become widely used in recent years, and individuals and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
